NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,446,000 | -3.6% | 37,744 | +1.5% | 1.38% | -14.2% |
| Q1 2019 | $3,576,000 | -88.7% | 37,193 | +0.6% | 1.60% | +6.4% |
| Q4 2018 | $31,732,000 | +885.8% | 36,980 | -2.7% | 1.51% | +12.1% |
| Q3 2018 | $3,219,000 | +12.8% | 37,995 | +0.6% | 1.35% | +7.9% |
| Q2 2018 | $2,854,000 | -2.6% | 37,783 | +4.2% | 1.25% | +0.1% |
| Q1 2018 | $2,931,000 | -2.1% | 36,250 | +1.7% | 1.25% | +2.0% |
| Q4 2017 | $2,993,000 | -0.7% | 35,644 | +1.5% | 1.22% | -3.3% |
| Q3 2017 | $3,014,000 | +3.3% | 35,103 | +0.4% | 1.26% | -2.5% |
| Q2 2017 | $2,917,000 | +6.3% | 34,946 | -5.4% | 1.30% | +5.0% |
| Q1 2017 | $2,744,000 | +1.4% | 36,952 | -0.5% | 1.24% | -2.0% |
| Q4 2016 | $2,707,000 | -8.5% | 37,150 | -0.9% | 1.26% | -8.4% |
| Q3 2016 | $2,960,000 | -4.1% | 37,480 | +0.2% | 1.38% | -7.2% |
| Q2 2016 | $3,086,000 | +16.0% | 37,404 | +1.9% | 1.48% | +0.3% |
| Q1 2016 | $2,660,000 | – | 36,721 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |